Participation of endogenous opiates in regulation of the hypothalamic-pituitary-testicular axis in normal men.
To assess the influence of endogenous opioids on human gonadotropin secretion, integrated concentrations of gonadotropins during 24-h naloxone infusion (2.08 mg/h) were examined in a group of six normal men. Naloxone significantly stimulated LH secretion in all subjects, whereas serum FSH levels were similar during both saline and naloxone infusion. Serum testosterone, dihydrotestosterone, and 17 alpha-hydroxyprogesterone levels increased during the infusion of naloxone, but the delta 4-androstenedione concentration was not modified. The frequency and amplitude of LH secretory episodes were clearly increased when an equal amount of the drug was given and LH concentrations were measured every 15 min for 6 h. The results suggest the endogenous opioids inhibit the hypothalamic-pituitary-gonadal axis in normal men.
D019326:17-alpha-Hydroxyprogesterone; D000328:Adult; D013196:Dihydrotestosterone / Q000097:blood; D004723:Endorphins / Q000502:physiology*; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D006908:Hydroxyprogesterones / Q000097:blood; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology*; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D009270:Naloxone / Q000008:administration & dosage; D013737:Testis / Q000502:physiology*; D013739:Testosterone / Q000097:blood
D004723:Endorphins; D006908:Hydroxyprogesterones; D013196:Dihydrotestosterone; D009270:Naloxone; D013739:Testosterone; D019326:17-alpha-Hydroxyprogesterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone